HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cannabis/CBD

Set Alert for Cannabis/CBD

Cosmetic And Personal Care Weekly Trademarks Review: 21 March

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches

Bill Steering Hemp In Supplements To NDI Notification Pathway Introduced For Third Time

Virginia Republican Morgan Griffith has same message for FDA he’s previously stated about hemp ingredients. Agency “has dragged its feet in properly regulating CBD and hemp-derived products on the market, creating confusion about its legal uses,” he says.

Cannabidiol CBD FDA

Cosmetic And Personal Care Weekly Trademarks Review: 14 March

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches

CIR Expert Panel To Prioritize Cannabidiol Review In 2024 At FDA’s Request

Cosmetic Ingredient Review’s independent experts note that CBD use in cosmetic products has increased since FDA first asked them to prioritize its review in 2020.

Cosmetic Ingredients Cannabidiol CBD

De-scheduling Hemp As Controlled Substance Left Behind Clouds Of Confusion Despite Being Lawful

While 2018 farm bill removed hemp –from US list of controlled substances, it sustained prohibition against participation in hemp production by convicted felons who’ve completed their sentences.

Cannabidiol CBD Legislation

Will DEA Saying Synthetic THCs Are Controlled Substances Help Deliver Lawful Hemp Answer?

DEA’s explanation delta-8 THC acetate isn’t hemp, along with FDA’s hemp and cannabis policies chief saying it and other cannabis derivatives aren’t hemp, should simplify decision on lawful use of hemp in non-drug products subject to FDA’s regulatory oversight.

Cannabidiol CBD FDA

CBD For Smoking Cessation? Study Shows Possible Benefits For Curbing Tobacco Use

A metabolite of CBD inhibits a key enzyme for nicotine metabolism, US researchers have found, potentially allowing nicotine users to wait before feeling the need to inhale more cigarette smoke. CBD shows promise, therefore, as a smoking cessation therapy, the study suggests. 

US States Health

Cosmetic And Personal Care Weekly Trademarks Review: 7 March

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches
See All
UsernamePublicRestriction

Register